from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1838c/vapC13

LFCtreatmentdescriptionclass of inhibitor

0.342

Amikacinug/mL Amikacintranslation

1.439

Cap5-10ug/mL Capreomycintranslation

1.039

Rox10-50 ug/mL Roxithromycintranslation

-0.961

SM2-5 ug/mL Streptomycintranslation

1.066

Tet5-10 ug/mL Tetracyclinetranslation

1.054

Rif0.2-5ug/mL Rifampicintranscription

0.206

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.734

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.836

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.383

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.294

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.422

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.178

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.295

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.909

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.175

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.700

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.135

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.089

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.086

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.814

KCN5-20 ug/mL Potassium cyaniderespiration

-0.449

NaN30.2-2 mM Sodium aziderespiration

-0.204

Nigericin50 uM Nigericinrespiration

0.428

TRC10-150 ug/mL Triclosanrespiration

1.168

TRZ10-25 ug/mL Thioridazinerespiration

0.887

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.751

menadione6-10 ug/mL Menadionerespiration

0.388

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.456

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.018

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.661

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.290

NRP_1Non-replicating persistence stage 1dosRassociated

-0.949

Amp0.2mg/mL AmpicillincellWall

-0.440

Cephalexin20-100 ug/mL CephalexincellWall

-0.132

Cerulenin0.32-5 ug/mL CerulenincellWall

0.178

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.180

EMB10-20 ug/mL EthambutolcellWall

-1.395

Eta12-40 ug/mL EthionamidecellWall

-1.447

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.557

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.726

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.742

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.139

BZA0.12 mg/mL BenzamidearomaticAmides

0.154

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.539

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.296

H2O24 mM hydrogen peroxideDNAdamaging

-0.146

Levo10 ug/mL LevofloxacinDNAdamaging

-0.509

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.512

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.032

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.054

UVUV-irradiationDNAdamaging

1.199

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.309

Antimycin12.5-50 ug/mL Antimycin A?

-0.778

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.382

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.394

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.245

PA8240.2-2 ug/mL PA-824?

-0.132

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.136

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.011

Verapamil50 uM Verapamil?

-0.163

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.834

methoxatin10-20 ug/mL Methoxatin?